$AFRM

A buy now, pay later stock has been sliding. It's worth scooping up, Wolfe Research says

Wolfe Research upgraded Affirm Holdings (AFRM) to outperform with a $90 price target, citing strong fundamentals and growth opportunities. AFRM shares have fallen 8% since Aug. 27, underperforming competitors and the S&P 500. Analyst Darrin Peller highlights Affirm's share gains, card momentum, and international expansion potential.

Original reporting
Published Sep 14, 2026, 11:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 12:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
A buy now, pay later stock has been sliding. It's worth scooping up, Wolfe Research says — source image
Decision brief

The 30-second read

$AFRMBullishHigh
01

Why it matters

The upgrade provides a clear catalyst for short‑term buying, with the analyst highlighting international expansion and vertical diversification as growth levers.

02

Market read

Analyst upgrade with a concrete price target can drive immediate buying interest, especially after a recent price decline.

03

What to watch

Potential regulatory scrutiny of BNPL practices and macro‑consumer spending slowdown could dampen upside.

Relevance 7/10Novelty 7/10Timing: Monday

Background

Wolfe Research issued an upgrade to outperform for AFRM, raising its price target to $90 after the stock fell 8% post‑Q4 earnings.

Company-level read

Ticker impact

$AFRMBullishHigh confidence
Context

Wolfe Research upgraded AFRM to outperform with a $90 price target, citing valuation and growth drivers after the stock slid 8% since its Q4 earnings.

Expected impact

Potential 5‑10% rally over the next few days if investors act on the new target.

Evidence & confidence

The upgrade is a fresh, primary analyst action with a concrete target; market often reacts positively to such signals on a mid‑cap stock.

Market effects

Positive for the broader BNPL/pay‑later sector as the upgrade may lift peer sentiment.

U.S. equity markets, especially fintech and consumer finance stocks, could see modest buying pressure.

Limited to markets with exposure to U.S. fintech equities.

Counterpoint

The stock may still be overvalued at $90 given recent earnings volatility and competitive pressure from Klarna.

Key entities

  • Affirm Holdings

    U.S. buy‑now‑pay‑later fintech firm (ticker AFRM).

  • Wolfe Research

    Equity research boutique that issued the upgrade.

Related articles

$AFRMMed

Is Affirm Holdings, Inc. (AFRM) Stock a Buy After Goldman Sachs Raised Its Price Target?

Affirm Holdings (AFRM) saw its price target raised by Goldman Sachs to $115 from $106, citing strong Q4 results with revenue up 33% to $1.2B and operating income up $89M. The company's growth is driven by increased interest-bearing loans and the Affirm Card, with active cardholders doubling. However, risks include credit quality and competition in the BNPL space. Hedge fund holdings declined, and short interest is modest.

$AFRMMed

Affirm (AFRM) Stock Surges 5% on Transformer AI Model Launch for Credit Decisions

Affirm (AFRM) stock rose 5.5% premarket after launching an AI model for instant loan approvals, improving transaction completion rates by 3.4%. The system uses 14 years of proprietary data. Chief Accounting Officer Siphelele Jiyane sold $1.95M in shares. Analysts have a 'Moderate Buy' rating with a $98.78 price target, above the current $71.58. Q2 earnings beat estimates with $4.62 EPS and $1.07B revenue.

$AFRMMed

Affirm stock surges on new AI model for loan approvals

Affirm Holdings Inc (AFRM) shares rose 5.5% premarket after launching an AI model for real-time loan approvals. The model, live in the U.S., uses machine learning to analyze credit history, approving more loans with better performance. According to the company, it increased completed purchases by 3.4% compared to a control group. The technology aims to responsibly expand credit access without compromising repayment rates.

$AFRMMedAI 8/10

Goldman Sachs Is Bullish. Here Are 3 Reasons AFRM Stock Could Climb 69%.

Goldman Sachs and other firms raised their price targets for Affirm (AFRM), with a mean target of $99.48 and a high of $124. The company reported strong Q4 results, with interest income up 30% YOY and net income reaching $1.6 billion. Growth was driven by the Affirm Card, which saw active cardholders double and GMV surge 124%. The company also has significant growth potential in expanding its merchant network and new markets.